Clinical commissioning policy: treatments for Graft versus Host Disease (GvHD) following haematopoietic stem cell transplantation

Document first published:
Page updated:
Topic:
Publication type:
NHS England will commission treatments for Graft versus Host Disease (GvHD) following haematopoietic stem cell transplantation in accordance with the criteria outlined in this document.

Document

Clinical commissioning policy: treatments for Graft versus Host Disease (GvHD) following haematopoietic stem cell transplantation

Clinical commissioning policy: treatments for Graft versus Host Disease (GvHD) following haematopoietic stem cell transplantation

  • PDF
  • 159 KB
  • 9 pages

Summary

This document updates:

  • Clinical commissioning policy: Treatments for Graft versus Host Disease (GvHD) following haematopoietic stem cell transplantation (2017)

Updated July 2025.

Document

Equality and health inequalities impact assessment: treatments for Graft versus Host Disease (GvHD) following haematopoietic stem cell transplantation

Equality and health inequalities impact assessment: treatments for Graft versus Host Disease (GvHD) following haematopoietic stem cell transplantation

  • PDF
  • 160 KB
  • 14 pages

Summary

Updated July 2025.